News
Paragonix Technologies Sponsors Lung Transplant Hiking Expedition
Paragonix Technologies is immensely proud to sponsor one of the most amazing sporting events of 2019: an expedition of a group of 50 patients and medical professionals to the highest mountain of North Africa, Jebel Toubkal (4200m). What’s so incredible about these patients? They have reached the peak of Jebel Toubkal
The Favaloro Foundation First in South America to Preserve & Transport Donor Heart with Paragonix
CAMBRIDGE, Massachusetts & Buenos Aires, Argentina—Paragonix Technologies, Inc. today announced that the Paragonix SherpaPak™ Cardiac Transport System (CTS), the industry’s only FDA cleared and CE marked system for donor heart transport and storage, was used for the first time in South America at the Favaloro Foundation University Hospital. The Paragonix SherpaPak™ CTS safeguards
Paragonix SherpaPak™ Cardiac Transport System to be Featured in Clinical Presentation at 2019 American Transplant Congress
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. today announced that the Paragonix SherpaPak™ Cardiac Transport System (CTS), the industry’s only FDA cleared and CE marked system for donor organ heart transport and storage, will be featured in a clinical presentation at the 2019 American Transplant Congress. The meeting is being held June 1-5, 2019 in Boston.
Paragonix Announces Transplanted-Cost Savings & Clinical Results for Donor Heart Preservation using SherpaPak Cardiac Transport System in Routine & Complex Heart Transplantation
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. today announced clinical results presented during the Paragonix SherpaPak™ CTS 2019 International Heart Summit held during the International Society for Heart and Lung Transplantation (ISHLT) 2019 Annual Meeting in Orlando, FL. Five U.S. and European Centers shared clinical use experiences of the Paragonix SherpaPak™ Cardiac Transport System (CTS) for the preservation of donor hearts destined for heart transplantation.
Paragonix & the Lung Transplant Foundation Announce Expansion of Partnership to Accelerate Commercialization of Innovative Lung Preservation Technologies
CAMBRIDGE, Mass.–(BUSINESS WIRE)– Paragonix Technologies Inc., and the Lung Transplant Foundation (LTF) today announced an expansion of their partnership for the development of a series of innovative technologies for improved donor lung preservation.At a joint meeting held during the International Society for Heart and Lung Transplantation (ISHLT) 2019 Annual Meeting in Orlando, FL, The
Paragonix Initiates Global Post Market Registry Evaluating Clinical Outcomes in Patients who Receive Donor Hearts Transported with Paragonix SherpaPak™ Cardiac Transport System
CAMBRIDGE, Mass.–(BUSINESS WIRE)– Paragonix Technologies, Inc. today announced the opening of the Global Utilization And Registry Database for Improved heArt preservatioN (“GUARDIAN”) post-market registry, which will assess clinical outcomes when employing the Paragonix SherpaPak™ Cardiac Transport System (CTS) for heart transplantations. “Clinical feedback regarding the Paragonix SherpaPak™ CTS has been extremely encouraging and we
